Galectin Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for fibrotic diseases and cancer. The company primarily targets metabolic dysfunction-associated steatohepatitis (MASH) with cirrhosis and certain cancers.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.